Skip to content

AXGN

Axogen, Inc.

NASDAQ · Healthcare · Medical - Devices · US

$35.24
+1.79%
Ask drillr
Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open
$34.86
From 52W high
−31.88%
Volume
735472.00
Market cap
$2.07B
P/E (Fwd)
54.1x
EV/EBITDA
−159.3x
P/E (TTM)
—
RSI (14)
27.0
1D Return
+1.79%
YTD Return
+5.41%
SummaryUpdated Jun 1, 2026

AxoGen, Inc. (NASDAQ:AXGN) is a medical device company founded in 1986 and headquartered in Alachua, Florida. The company specializes in developing and marketing surgical solutions for peripheral nerve repair and reconstruction. AxoGen has evolved from its early days to become a leading provider of biologically-based nerve repair products, serving surgeons across multiple specialties including plastic reconstruction, orthopedic hand surgery, and oral and maxillofacial surgery. The company operates primarily in the United States but has expanded internationally to Canada, Germany, the United Kingdom, South Korea, and other markets.

Similar companies

Latest newsMore news →